Celularity (CELUW) Non-Current Assets (2018 - 2025)

Celularity (CELUW) reported Non-Current Assets of $95.0 million for Q4 2025, down 15.26% year-over-year from $112.1 million in Q4 2024, and down 8.33% quarter-over-quarter from $103.6 million in Q3 2025.

Celularity (CELUW) Non-Current Assets (2018 - 2025) Analysis & Trends

Celularity (CELUW) has 8 years of Non-Current Assets data on file, last reported at $95.0 million in Q4 2025.

  • Non-Current Assets for Q4 2025 came in at $95.0 million, down 15.26% year-over-year; the trailing twelve-month figure through Dec 2025 was $408.5 million (down 12.19% YoY), and the FY2025 annual result was $95.0 million, down 15.26% from the prior year.
  • Non-Current Assets slipped to $95.0 million in Q4 2025 per CELUW's latest filing, from $103.6 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $374.0 million in Q3 2022 and troughed at $95.0 million in Q4 2025.
  • A 5-year average of $214.5 million and a median of $134.5 million in 2021 frame the typical range for Non-Current Assets.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Assets jumped 175.7% in 2022, then slumped 66.24% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $355.0 million in 2021, then gained by 3.53% to $367.6 million in 2022, then sank by 66.24% to $124.1 million in 2023, then decreased by 9.65% to $112.1 million in 2024, then retreated by 15.26% to $95.0 million in 2025.
  • Business Quant data shows CELUW's Non-Current Assets at $95.0 million in Q4 2025, $103.6 million in Q3 2025, and $103.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Celularity - - -3.27 Mn 95.01 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 95.01 Mn
Sep 30, 2025 103.64 Mn
Jun 30, 2025 103.02 Mn
Mar 31, 2025 106.80 Mn
Dec 31, 2024 112.12 Mn
Sep 30, 2024 114.34 Mn
Jun 30, 2024 117.76 Mn
Mar 31, 2024 120.96 Mn
Dec 31, 2023 124.10 Mn
Sep 30, 2023 140.69 Mn
Jun 30, 2023 228.38 Mn
Mar 31, 2023 337.41 Mn
Dec 31, 2022 367.56 Mn
Sep 30, 2022 374.02 Mn
Jun 30, 2022 353.88 Mn
Mar 31, 2022 358.46 Mn
Dec 31, 2021 355.03 Mn
Sep 30, 2021 357.01 Mn
Jun 30, 2021 128.36 Mn
Mar 31, 2021 291.83 Mn